ETON
Eton Pharmaceuticals Inc
NASDAQ: ETON · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$24.12
+2.29% today
Updated 2026-04-30
Market cap
$628.09M
P/E ratio
—
P/S ratio
7.86x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$13 – $27
Volume
0.4M
Eton Pharmaceuticals Inc (ETON) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-29.0%
Last 4 quarters
Revenue YoY growth
+82.7%
Most recent quarter
EPS YoY growth
+1050.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-12.2%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-12 | $0.19 | +5.6% | $18.09 | $18.93 | +4.6% |
| 2025-11-06 | $0.04 | -63.6% | $19.25 | $16.90 | -12.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.18 | $0.19 | +5.6% | $21.28M | +82.7% |
| 2025-09-30 | $0.11 | $0.04 | -63.6% | $22.46M | +117.5% |
| 2025-06-30 | $0.01 | $-0.10 | -1100.0% | $18.93M | +108.6% |
| 2025-03-31 | $-0.02 | $-0.06 | -200.0% | $17.28M | +116.9% |
| 2024-12-31 | $-0.00 | $-0.02 | -506.1% | $11.65M | +59.3% |
| 2024-09-30 | $-0.01 | $0.02 | +300.0% | $10.32M | +46.9% |
| 2024-06-30 | $-0.07 | $-0.12 | -71.4% | $9.07M | -24.4% |
| 2024-03-31 | $-0.07 | $-0.03 | +57.1% | $7.97M | +50.2% |
| 2023-12-31 | $-0.04 | $-0.09 | -125.0% | $7.31M | — |
| 2023-09-30 | $-0.10 | $-0.02 | +80.0% | $7.03M | — |
| 2023-06-30 | $-0.09 | $0.15 | +266.7% | $12.00M | — |
| 2023-03-31 | $-0.14 | $-0.10 | +28.6% | $5.30M | — |
Frequently asked questions
Has Eton Pharmaceuticals Inc beaten earnings estimates?
Eton Pharmaceuticals Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -29.0% over the last 2 quarters.
How does ETON stock react to earnings?
ETON stock has moved an average of -3.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Eton Pharmaceuticals Inc's revenue growth rate?
Eton Pharmaceuticals Inc reported year-over-year revenue growth of +82.7% in its most recent quarter, with EPS growing +1050.0% year-over-year.